Clinical Council

bern-001.jpg - large



Professor Bernard Yan 


Professor Bernard Yan is both Neurologist and Endovascular Neurointerventionist in Royal Melbourne Hospital, Australia. His clinical expertise is in stroke intervention and aneurysms. Since employment in 2005 at the Department of Medicine, University of Melbourne, Bernard Yan has pursued an academic interest in cerebrovascular disease research. He has published 186 academic papers in peer-reviewed medical journals (SCI) achieving an h-index of 32 with > 7000 citations. He is the principal investigator of several international studies in cerebrovascular diseases including DIRECT-SAFE in which he is the co-principal together with Professor Peter Mitchell. He is the awardee of academic grants by the National Health and Medical Research Council (NHMRC). His other key research interests include the development of portable mobile wireless sensors for the intensive monitoring of patients with neurological diseases. He is actively involved in the development of novel microcatheters for the treatment of cerebrovascular diseases. He is also the co-inventor and holder of patent of the Neuroglide micronavigational system. His administrative responsibilities include Treasurer (2014 onwards) of the World Stroke Organization (WSO) and Vice-President of the Stroke Society of Australasia. He is the founding organizer of the Australia and China Training Initiative of Neurology (ACTION) programme. The programme is in its 9th year of operations and has successfully trained over 300 young neurologists from China.




photo.JPG - large



A/Professor Andrew Lee 

A/Prof. Andrew Lee is a stroke trained neurologist and is currently the Regional Director of Stroke Medicine, Adelaide Health Service, Southern Cluster based at Flinders Medical Centre. He completed his medical training at the University of Adelaide, and both an Internal Medicine and Neurology residency at the Queen Elizabeth Hospital. He continued on to a Stroke Research Fellowship in the Department of Cerebrovascular Neurology, at the Johns Hopkins University School of Medicine and Hospital under the mentorship of Professor Argye Hillis. He received a Masters of Public Health from the Bloombergs School of Public Health, Johns Hopkins University with a capstone project on the management of TIA. On returning to Adelaide he was awarded a NHMRC ? NICS Fellowship to research more efficient ways of implementing thrombolysis in acute ischemic stroke. He has authored more than 20 articles on stroke related topics and has an interest in retinovascular disorders as well as perfusing imaging and amyloid angiopathy. He is the current chair of the Australian Stroke Unit Network and chairs the education and workforce committee of the Australian Stroke Coalition.




















Professor Mark Parsons


Mark Parsons is an internationally recognised leader in Stroke Research and is a national leader in Stroke and Neurology clinical service and education. He holds the Royal Melbourne Hospital Professorial Chair of Neurology, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and is the new Director of the Department of Neurology, Royal Melbourne Hospital. He is an Honorary Professorial Fellow, The Florey Institute of Neuroscience and Mental Health. He is also an Honorary Professor at Fudan University, Shanghai.


Prof Parsons is the immediate past president of the Stroke Society of Australasia and has chaired the Australasian Stroke Trials Network. He has recently been elected to the Australian and New Zealand Association of Neurologists (ANZAN) Council. He has served on steering committees for >10 major stroke clinical trials, including leadership of the pioneering phase II and phase III clinical trials of tenecteplase. Previously he has been the Director, Priority Research Centre for Stroke and Traumatic Brain Injury, University of Newcastle, Member; Hunter Medical Research Institute Board (Area Health Service Representative), Professor of Medicine (Neurology), Faculty of Health and Medicine, University of Newcastle and Director, Acute Stroke Service, John Hunter Hospital, Newcastle.


Prof Parsons’ work using magnetic resonance and CT imaging techniques to study stroke pathophysiology and new therapeutic approaches, and translate them into clinical practice is internationally recognised. He is the Winner, NSW Health Awards, Translational Research Category: Transforming Acute Stroke Care Locally and Globally (2015); the Hunter Medical Research Institute Director’s Award for Mid-Career Research (2014); the University of Newcastle Alumni Medal Winner for outstanding achievement (2012). This is the major annual award for Alumni of the University of Newcastle. He was awarded the Faculty of Health Award for Researcher of the Year in 2011; and the ANZAN Leonard Cox Award in 2008. This is awarded for significant contributions to neuroscience research in the 10 years since becoming a neurologist.





Professor Henry Ma


Professor Henry Ma is the Director of the Neurology Department and Head of Stroke Unit at Monash Health. He is a Clinical Adjunct Associate Professor at the Department of Medicine (Southern Clinical School) of Monash University. His PhD is on "Imaging the Penumbra in Acute Stroke" at the University of Melbourne. His special research interests are in the imaging of the ischaemic penumbra and acute stroke clinical trials. He has published many papers on these topics and has recently completed and presented the result of the EXTEND clinical trial, a multicentred thrombolysis trial in extended time window in acute ischemic stroke. He has also commenced the first amniotic epithelial stem cell for acute ischemic stroke trial in Australia (I-ACT). He is currently the Co-Chair of Australasia Stroke Trial Network. He and Professor Mark Parsons have recently won the bid to host the 2021 Joint Asia Pacific Stroke Organisation / Stroke Society of Australasia scientific Conference in Melbourne. He also has extensive research collaboration in Asia pacific region.







Professor Stephen Davis

Professor Stephen Davis is the inaugural Professor of Translational Neuroscience at the University of Melbourne. He is based at the Royal Melbourne Hospital (RMH) where he is the Director of Neurosciences and Continuing Care, Director of Neurology and Director of the Melbourne Brain Centre (MBC) at the RMH. The MBC at RMH is funded a Centre of Research Excellence (CRE) grant from the NHMRC. He is the current President of the World Stroke Organization and Co-Chair of the World Stroke Academy. He is the immediate past-President of the Australian and New Zealand Association of Neurologists (ANZAN) and a past-President of the Stroke Society of Australasia. He was the first Co-chair of the Australasian Stroke Trials network and has extensive experience in stroke trials. He is the Co-Chair, with Geoffrey Donnan, of Neuroscience Trials Australia (NTA). He is a Consulting Editor for Stroke and on a number of other editorial boards. He has been a trustee of the RMH Neuroscience Foundation since its formation in 1992. He was given the M.J. Eadie Award in 2004 by the Australian and New Zealand Association of Neurologists for career achievements in neuroscience research and the Victorian Health Minister?s Award in 2008 for outstanding individual achievement, in the Victorian Public Healthcare awards. He was the 2011 recipient of the William Feinberg Award from the American Stroke Association for excellence in clinical stroke research. He was the 2011 recipient of the Bethlehem Griffiths Research Foundation medal. In 2012, he has been given the E Graeme Robertson award by the Australian and New Zealand Association of Neurologists for career achievements for Neuroscience. He is the joint recipient of a current NHMRC program grant in stroke and the Principal Investigator of the NHMRC grant in Clinical Research Excellence at the Royal Melbourne Hospital. He has co-authored 3 books, numerous book chapters, and over 340 peer-reviewed papers